• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR PIPELINE EMBOLIZATION DEVICE INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR PIPELINE EMBOLIZATION DEVICE INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hemorrhage, Cerebral (1889); Therapeutic Response, Decreased (2271)
Event Date 07/07/2018
Event Type  Death  
Manufacturer Narrative
Bhogal, p. , chudyk, j. , bleise, c. , lylyk, i. , perez, n. , henkes, h. , <(>&<)> lylyk, p. (2018). The use of flow diversion in vessels
=
2. 5 mm in diameter¿a single-center experience. World neurosurgery, 118. Doi:10. 1016/j. Wneu. 2018. 06. 245 the pipeline device will not be returned for evaluation as it was implanted in the patient. Based on the reported information, there does not appear to have been any defect of the device during use. The event occurred in the patient post-procedure and its cause could not be conclusively determined from the reported information. Mdrs related to this article: 2029214-2018-00933 2029214-2018-00934. If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic literature review found reports of post-procedure complications after pipeline implantation. The purpose of this article was to review the use of flow diversion on vessels less than or equal to 2. 5mm in diameter. The authors retrospectively reviewed patient data and identified 29 patients (22 female, 7 male) with an average age of 56 years who underwent flow diversion treatment of aneurysms. The article notes the following outcomes of pipeline patients: patient 9 ((b)(6), male) underwent placement of a pipeline 3x20 (pli 20) n the treatment of a dissecting aneurysm in the right mca bifurcation. The patient had worsening symptoms of compression and therefore underwent retreatment; however, the patient had a hemorrhagic stroke, which led to death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NamePIPELINE EMBOLIZATION DEVICE
Type of DeviceINTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key8061839
MDR Text Key126882302
Report Number2029214-2018-00933
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation
Type of Report Initial
Report Date 11/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received10/18/2018
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 11/12/2018 Patient Sequence Number: 1
-
-